Comparing diabetes drugs--helping clinical decisions?

Lancet. 2013 Jan 12;381(9861):93-4. doi: 10.1016/S0140-6736(12)61576-1. Epub 2012 Nov 7.
No abstract available

Publication types

  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Exenatide
  • Glucagon-Like Peptide 1 / analogs & derivatives*
  • Glucagon-Like Peptide 1 / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Liraglutide
  • Male
  • Peptides / therapeutic use*
  • Venoms / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Peptides
  • Venoms
  • Liraglutide
  • Glucagon-Like Peptide 1
  • Exenatide